Literature DB >> 7545789

Nitric oxide synthase activity is inducible in rat, but not rabbit alveolar macrophages, with a concomitant reduction in arginase activity.

C Hey1, I Wessler, K Racké.   

Abstract

Alveolar macrophages were obtained by broncho-alveolar lavage of isolated rat and rabbit lungs and cultured (2.5 x 10(6) cells/dish) for 18 h in the absence or presence of bacterial lipopolysaccharides (LPS) alone or in combination with cytokines. Thereafter, accumulation of 3H-citrulline (NO synthase activity) and 3H-ornithine (arginase activity) were determined. During incubation of rat alveolar macrophages with 3H-arginine clear amounts of 3H-citrulline and 3H-ornithine (3.8 and 4.6% of the added 3H-arginine, respectively) were formed and most of these metabolites appeared in the incubation medium (ratios extra-/intracellular of 17 and 70 for 3H-citrulline and 3H-ornithine, respectively). When rat alveolar macrophages had been cultured with LPS the formation of 3H-citrulline was increased about 30-fold and this was accompanied by a reduction in 3H-ornithine formation of about 60%. The effects of LPS were largely attenuated by dexamethasone (10 mumol/l). Inhibition of NO synthase by NG-monomethyl-L-arginine (L-NMMA, 100 mumol/l) in LPS treated alveolar macrophages reduced the formation 3H-citrulline by more than 90% and restored the 3H-ornithine formation. After culturing in the presence of LPS the ratios extra/intracellular of 3H-citrulline and 3H-ornithine were markedly enhanced and this effect was not dexamethasone sensitive.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545789     DOI: 10.1007/bf00170166

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

1.  Alveolar macrophages. I. A simple technique for the preparation of high numbers of viable alveolar macrophages from small laboratory animals.

Authors:  P G Holt
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

2.  A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells.

Authors:  R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

3.  Tumor-cytotoxicity of nitric-oxide produced from alveolar macrophages directly stimulated with tumor-cells.

Authors:  Y Nozaki; K Isobe; I Nakashima; K Shimokata
Journal:  Int J Oncol       Date:  1993-06       Impact factor: 5.650

4.  Nitric oxide and airways.

Authors:  P J Barnes
Journal:  Eur Respir J       Date:  1993-02       Impact factor: 16.671

5.  The urea cycle in different types of macrophages.

Authors:  F Hofmann; J Kreusch; K P Maier; P G Munder; K Decker
Journal:  Biochem Soc Trans       Date:  1978       Impact factor: 5.407

6.  L-arginine-dependent production of nitrogen oxides by rat pulmonary macrophages.

Authors:  P G Jorens; F J Van Overveld; H Bult; P A Vermeire; A G Herman
Journal:  Eur J Pharmacol       Date:  1991-08-06       Impact factor: 4.432

7.  Selective inhibition by dexamethasone of induction of NO synthase, but not of induction of L-arginine transport, in activated murine macrophage J774 cells.

Authors:  A R Baydoun; R G Bogle; J D Pearson; G E Mann
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

Review 8.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

Review 9.  Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.

Authors:  U Förstermann; E I Closs; J S Pollock; M Nakane; P Schwarz; I Gath; H Kleinert
Journal:  Hypertension       Date:  1994-06       Impact factor: 10.190

10.  Effect of lipopolysaccharide on transport and metabolism of arginine in mouse peritoneal macrophages.

Authors:  H Sato; M Fujiwara; S Bannai
Journal:  J Leukoc Biol       Date:  1992-08       Impact factor: 4.962

View more
  8 in total

1.  Influence of the Ward colon tumor on the host response to endotoxin.

Authors:  V B Grossie; D Mailman
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Inhibition of nitric oxide synthase abrogates lipopolysaccharides-induced up-regulation of L-arginine uptake in rat alveolar macrophages.

Authors:  R Hammermann; C Stichnote; E I Closs; H Nawrath; K Racké
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

3.  Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages.

Authors:  S Klasen; R Hammermann; M Fuhrmann; D Lindemann; K F Beck; J Pfeilschifter; K Racké
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

4.  Stimulation-induced 3H-L-citrulline accumulation in isolated longitudinal muscle myenteric plexus preparations of rat small intestine: a measure to characterize nitrergic neurons.

Authors:  L Berrino; C Hey; F Rossi; K Racké
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

5.  Activation of L-arginine transport by protein kinase C in rabbit, rat and mouse alveolar macrophages.

Authors:  K Racké; C Hey; J Mössner; R Hammermann; C Stichnote; I Wessler
Journal:  J Physiol       Date:  1998-09-15       Impact factor: 5.182

6.  Protective role of Cys-178 against the inactivation and oligomerization of human insulin-degrading enzyme by oxidation and nitrosylation.

Authors:  Luis A Ralat; Min Ren; Alexander B Schilling; Wei-Jen Tang
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

7.  Glucocorticoid inhibition of interleukin-4 (IL-4) and interleukin-13 (IL-13) induced up-regulation of arginase in rat airway fibroblasts.

Authors:  Dirk Lindemann; Kurt Racké
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-15       Impact factor: 3.000

8.  Species differences in expression pattern of arginase isoenzymes and differential effects of arginase inhibition on collagen synthesis in human and rat pulmonary fibroblasts.

Authors:  M Warnken; S Haag; S Matthiesen; U R Juergens; K Racké
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-01-28       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.